Clinical Trial Update: A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing docetaxel plus fulvestrant versus docetaxel alone in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED